The US Food and Drug Administration (FDA) has approved Israeli Pharmaceutical Teva’s QNASL nasal aerosol for the treatment of nasal allergy rhinitis. Allergic rhinitis is the most common allergic disease in the US, affecting 10-30% of adults and adolescents.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000736459